Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04124432 · ClinicalTrials.gov registry record · Phase 1
Behavioral Pharmacology of Cannabis and Nicotine
A Phase 1 study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT04124432: Completed Phase 1 study, sponsored by Johns Hopkins University.
NCT04124432 is a Phase 1 study that has completed, run by Johns Hopkins University. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04124432, a Phase 1 study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study will evaluate the individual and interactive pharmacokinetic and pharmacodynamic effects of smoked cannabis and nicotine.
Interventions
- DRUG Nicotine
- DRUG Cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-09-15 |
| Est. Completion | 2023-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04124432
The ClinicalTrials.gov registry entry for NCT04124432 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nicotine is the first listed.
NCT04124432 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04124432 about?
NCT04124432 is a clinical study titled "Behavioral Pharmacology of Cannabis and Nicotine". This study will evaluate the individual and interactive pharmacokinetic and pharmacodynamic effects of smoked cannabis and nicotine.
What is the current status of trial NCT04124432?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2020-09-15. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT04124432?
The interventions under investigation include: Nicotine (DRUG), Cannabis (DRUG).
Who is sponsoring clinical trial NCT04124432?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.